Postoperative Inflammation Following Cataract Surgery

• FDA approval · 2018-02-09
  FDA Approved: DEXYCU — Original Application (EyePoint Pharmaceuticals US, Inc)

  The FDA granted original approval for DEXYCU (dexamethasone intraocular suspension) from EyePoint Pharmaceuticals US, Inc to treat postopera…

• FDA approval · 2015-11-10
  FDA Approved: ILEVRO — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for ILEVRO (nepafenac) submitted by Novartis Pharmaceuticals Corporation. This approval adds expande…

• FDA approval · 2014-02-13
  FDA Approved: ILEVRO — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for ILEVRO (nepafenac) from Novartis Pharmaceuticals Corporation. The supplemental action relates to…